Product NDC: | 10019-651 |
Proprietary Name: | Sevoflurane |
Non Proprietary Name: | Sevoflurane |
Active Ingredient(s): | 250 mL/250mL & nbsp; Sevoflurane |
Administration Route(s): | RESPIRATORY (INHALATION) |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10019-651 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075895 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111018 |
Package NDC: | 10019-651-64 |
Package Description: | 6 BOTTLE in 1 CARTON (10019-651-64) > 250 mL in 1 BOTTLE |
NDC Code | 10019-651-64 |
Proprietary Name | Sevoflurane |
Package Description | 6 BOTTLE in 1 CARTON (10019-651-64) > 250 mL in 1 BOTTLE |
Product NDC | 10019-651 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Sevoflurane |
Dosage Form Name | LIQUID |
Route Name | RESPIRATORY (INHALATION) |
Start Marketing Date | 20111018 |
Marketing Category Name | ANDA |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | SEVOFLURANE |
Strength Number | 250 |
Strength Unit | mL/250mL |
Pharmaceutical Classes | General Anesthesia [PE],General Anesthetic [EPC] |